US EditionBioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm
11 Articles
11 Articles
Ugur Sahin and Özlem Türeci leave Biontech. The big question that everyone is now asking themselves: Does the covid vaccine company remain a German success story even without the famous researchers? Anyone who asks experts and investors gets different answers than just a few days ago.
With the founders Uğur Şahin and Özlem Türeci, the company loses its "superpowers".
The founders of Biontech are withdrawing from the management of the Mainz-based company. The fact that Şahin and Türeci want to start over again is more than just a personality – but also a reference to the nature of innovation.
COVID-19 vaccine pioneers to leave BioNTech and focus on mRNA
The founders of the pharma firm BioNTech — who helped pioneer COVID-19 vaccines — are leaving the company to focus on research to advance mRNA technology. Uğur Şahin and Özlem Türeci, a Turkish husband-and-wife team, became unlikely celebrities during the pandemic: 366 million doses of BioNTech’s vaccine, developed with Pfizer, were administered in the US alone by 2023. It won the pair many awards and a huge fortune: Forbes estimated that Şahin …
With their covid vaccines, Ugur Sahin and Özlem Türeci became world famous overnight. Now the medical team prefers to research again instead of manage. About the comet-like rise of a company from Mainz – and the endless search for a breakthrough.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
